BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16861141)

  • 21. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
    Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.
    Benedetti F; Serretti A; Pontiggia A; Bernasconi A; Lorenzi C; Colombo C; Smeraldi E
    Neurosci Lett; 2005 Mar; 376(1):51-5. PubMed ID: 15694273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.
    Benedetti F; Bernasconi A; Lorenzi C; Pontiggia A; Serretti A; Colombo C; Smeraldi E
    Neurosci Lett; 2004 Jan; 355(1-2):37-40. PubMed ID: 14729229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.
    de Sousa RT; Zanetti MV; Talib LL; Serpa MH; Chaim TM; Carvalho AF; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    J Psychiatr Res; 2015 Mar; 62():78-83. PubMed ID: 25691093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population.
    Yoon HK; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):331-4. PubMed ID: 20015462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder.
    Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Kunugi H; Koyama T
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):83-8. PubMed ID: 15927087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder.
    Nishiguchi N; Breen G; Russ C; St Clair D; Collier D
    Neurosci Lett; 2006 Feb; 394(3):243-5. PubMed ID: 16289783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No association between the PREP gene and lithium responsive bipolar disorder.
    Mamdani F; Sequeira A; Alda M; Grof P; Rouleau G; Turecki G
    BMC Psychiatry; 2007 Feb; 7():9. PubMed ID: 17324276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.
    Lee YJ; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1303-8. PubMed ID: 21549170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
    Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
    J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
    Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Takeda M; Kunugi H; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):204-8. PubMed ID: 17822820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
    Pandey GN; Ren X; Rizavi HS; Dwivedi Y
    J Psychiatr Res; 2010 Feb; 44(3):143-8. PubMed ID: 19717166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.
    Serretti A; Benedetti F; Mandelli L; Calati R; Caneva B; Lorenzi C; Fontana V; Colombo C; Smeraldi E
    Psychiatry Res; 2008 Mar; 158(2):132-40. PubMed ID: 17976739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
    Benedetti F; Serretti A; Colombo C; Lorenzi C; Tubazio V; Smeraldi E
    Neurosci Lett; 2004 Sep; 368(2):123-6. PubMed ID: 15351432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
    Scassellati C; Rotondo A; Bonvicini C; Rossi G; Cassano GB; Gennarelli M
    Psychiatr Genet; 2007 Aug; 17(4):249-50. PubMed ID: 17621172
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].
    Altınbaş K; Yeşilbaş D; İnce B; Cansız A; Sılan F; Özdemir Ö; Gülöksüz S
    Turk Psikiyatri Derg; 2018; 29(2):73-78. PubMed ID: 30215834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder.
    Azab AN; Vainer E; Agam G; Bersudsky Y
    J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Suwalska A; Skibinska M; Szczepankiewicz A; Leszczynska-Rodziewicz A; Permoda A; Czerski PM; Hauser J
    Pharmacopsychiatry; 2005 Jul; 38(4):166-70. PubMed ID: 16025419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder.
    Duffy A; Turecki G; Grof P; Cavazzoni P; Grof E; Joober R; Ahrens B; Berghöfer A; Müller-Oerlinghausen B; Dvoráková M; Libigerová E; Vojtĕchovský M; Zvolský P; Nilsson A; Licht RW; Rasmussen NA; Schou M; Vestergaard P; Holzinger A; Schumann C; Thau K; Robertson C; Rouleau GA; Alda M
    J Psychiatry Neurosci; 2000 Sep; 25(4):353-8. PubMed ID: 11022400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.